Spondylitis by Candida albicans: Successful treatment with fluconazole;CANDIDA-ALBICANS-SPONDYLITIS: ERFOLGREICHE BEHANDLUNG MIT FLUCONAZOL

Praxis

Volumn 85, Issue 16, 1996, Pages 520-525

  Rosler Meier, D ^a   Brunner La Rocca, H P ^b   Senn, P ^a   Schlumpf, U ^a,c  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Kantonsspital Luzern Medizinische Klinik   (Switzerland)

Author keywords

candida albicans; fluconazole; spondylitis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RADIOGRAPHY; SPONDYLITIS;

AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; FLUCONAZOLE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SPONDYLITIS;

EID: 0029873298     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lafont A., Olivé A., Gelman M., Roca-Rurniols J., Cots R., Carbonell J.: Candida albicans spondylodiscitis and vertebral osteomyelitis in patients with intravenous heroin drug addiction. Report of 3 new cases. J. Rheumatol. 21, 953-956, 1994.
2. Collet Ph., Biron P., Larbre J. P, Llorca G., Lejeune E.: Spondylodiscites à candida. A propos de 2 observations personnelles et de 28 observations de la littérature. Rev Med. Interne 10, 413-419, 1989.
3. Duquesnoy B., Berniére L , Gougeon F., Andrieux S., Delcambre B.: Les arthrites à candida. A propos d'une spondylodiscite et d'une coxite traitées par le kétoconazole. Rev. Rhum. Mal. Osteoartic. 50, 615-617, 1983.
4. Karabinis A., Hill C., Leclercq B., Tancrede C., Baume D., Andremont A.: Risk factors for candidemia in cancer patients. A case-control study. J. Clin. Microbiol. 26, 429-432, 1988.
5. Harvey R. L., Myers J. P.: Nosocomial fungernia in a large community teaching hospital. Arch. Intern. Med. 147, 2117-2120, 1987.
6. Waltzing-Koudine L., Breville P., Rajzbaum G., Waltzing P.: Spondylodiscite à candida albicans. Traitement par fluconazole seul. Presse Mëd 24, 505, 1995.
7. Sugar A. M , Saunders C , Diamond R. D.: Successful treatment of candida osteomyelitis with fluconazole. Diagn. Microbiol. Infect. Dis. 13, 517-520, 1990.
8. Tang C.: Successful treatment of candida albicans osteomyelitis with fluconazole. J. Infect. 26, 89-92, 1993.
9. Grant S. M., Clissold S. P. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39, 877-916, 1990.
10. Como J. A., Dismukes W. E.: Oral azole drugs as systemic antifungal therapy. New Engl. J. Med. 330, 263-272, 1994.
11. Goff D. A., Koletar S. L., Buesching W. J., Barnishan J., Fass R. J.: Isolation of fluconazole-resistant candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin. Infect. Dis. 20, 77-83, 1995.
12. Rex J H , Rinaldi M. G., Pfaller M. A.: Resistance of candida species to fluconazole. Minireview. Antimicrob. Agents Chemother. 39, 1-8, 1995.
13. Pohjola-Sintonen S., Ruutu P., Tallroth K.: Hematogenous Candida spondylitis. A case report. Acta Med. Scand. 215, 85-87, 1984.
14. Dijkmans B. A. C., Koolen M. I., Mouton R. P , Falke T. H. M., van den Broek P. J., van der Meer J. W. M.: Hematogenous candida vertebral osteomyelitis treated with ketoconazole. Infection 10, 290-292, 1982.
15. Meunier F.: Management of candidemia. Editorial. New Engl. J. Med. 331, 1371-1372, 1994.
16. Rex J. H., Bennett J. E., Sugar A. M., Pappas P. G., van der Horst C. M., Edwards J. E., Washburn R. C., Scheld W. M., Karchmer A. W., Dine A. P., Levenstein M. J., Webb D C.: A randomized trial comparing fluconazole with amphothericin B for the treatment of candidemia in patients without neutropenia. New Engl. J. Med. 331, 1325-1330, 1994.
17. Fuziber J G., Squara P., Verdier J. M., Lapalus P., Gratecos N., Cassulo J. P , Chichmaniun R. M., Dujardin P., Spondylodiscite à candida albicans. Revue de la littérature à propos d'un cas avec étude de la pénétration osseuse de la 5-Fluorocytosine. Ann. Méd. Interne 133, 410-415, 1982.
18. Saint-Marc T., Gamier J. L., Meunier P., Cazes J. P , Piens M. A., Bochu M : Spondylodiscite à candida albicans chez un ancien toxicomane au cours du syndrome d'immunodéficience acquise (SIDA). Ann. Méd. Interne 140, 738-740, 1989.
19. Brammer K. W., Farrow P. R., Faulkner J. K.: Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12 (Suppl. 3), 318-326, 1990.
20. O'Meeghan T., Varcoe K., Thomas M., Ellis-Pegler R.: Fluconazole concentration in joint fluid during successful treatment of candida albicans septic arthritis. J. Antimicrob. Chemother. 26, 601-602, 1990.
21. Hennequin C., Labenne M., Benkerrou M., Hambourg M.: Fluconazole-resistant candida albicans in an immunocompetent child. Clin. Infect. Dis. 19, 1179-1180, 1994
22. Dan M., Priel I.: Failure of fluconazole therapy for sternal osteomyelitis due to candida albicans. Clin. Infect. Dis. 18, 127-128, 1994.
23. Edwards J. E., Foos R. Y., Montgomerie J. Z., Guze L. B.: Ocular manifestations of candida septicemia. Review of 76 cases of hematogenous candida endophthalmitis. Medicine 53, 47-75, 1974.
24. Urbak S. F., Degn T.: Fluconazole in the management of fungal ocular infections. Ophthalmologica 208, 147-156, 1994.
25. Urbak S. F., Degn T.: Fluconazole in the treatment of candida albicans endophthalmitis. Acta Ophthalmol. Copenh. 70, 528-529, 1992.
26. Laatikainen L., Tuominen M., von Dickhoff K.: Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy. Am. J. Ophthalmol. 113, 205-207, 1992.
27. Luttrull J. K., Lee Wan W., Kubak B. M., Smith M. D , Oster H. A.: Treatment of ocular fungal infections with oral fluconazole. Am. J. Ophthalmol. 119, 477-481, 1995.
28. O'Day D. M., Foulds G., Williams T. E., Robinson R. D., Alien R. H., Head W. S.: Ocular uptake of fluconazole following oral administration. Arch. Ophthalmol. 108, 1006-1008, 1990.